C
China National Accord Medicines Corp Ltd
SZSE:000028
China National Accord Medicines Corp Ltd
SZSE:000028
Price:
38.6 CNY
-0.97%
Market Closed
Updated:
May 22, 2024
China National Accord Medicines Corp Ltd
Cost of Revenue
|
China National Accord Medicines Corp Ltd
Cost of Revenue Peer Comparison
Comparables:
1099
601607
600998
C
600511
000963
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Cost of Revenue
-¥67.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-13%
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Cost of Revenue
-¥548.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-14%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Cost of Revenue
-¥234.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-13%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Cost of Revenue
-¥137.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-15%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Cost of Revenue
-¥46.7B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-17%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Cost of Revenue
-¥28B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-7%
|
See Also
What is China National Accord Medicines Corp Ltd's Cost of Revenue?
Cost of Revenue
-67.1B
CNY
-67.1B
CNY
Based on the financial report for Mar 31, 2024, China National Accord Medicines Corp Ltd's Cost of Revenue amounts to -67.1B CNY.
What is China National Accord Medicines Corp Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-13%
-13%
Over the last year, the Cost of Revenue growth was -2%. The average annual Cost of Revenue growth rates for China National Accord Medicines Corp Ltd have been -6% over the past three years , -11% over the past five years , and -13% over the past ten years .
You don't have any saved screeners yet
